|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 06/16/06 | Allergan : Obama's inversion curbs kill Pfizer's $160 billion Allergan deal | RE |
| 31/16/31 | Argus Media close to stake sale, Temasek among bidders - sources | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Eric Boyer
IRC | Investor Relations Contact | - | 03/02/2014 |
Carlos Pascual
PRN | Corporate Officer/Principal | - | 12/01/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel H. Yergin
BRD | Director/Board Member | 79 | 26/11/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.12% | -3.29% | -23.68% | +6.93% | 12TCr | ||
| -1.15% | +6.63% | -39.34% | -18.58% | 4.57TCr | ||
| -0.64% | -0.18% | -4.55% | +3.83% | 4.03TCr | ||
| -1.60% | -1.01% | -33.86% | -13.70% | 2.02TCr | ||
| -2.88% | +2.11% | -37.90% | -41.87% | 1.82TCr | ||
| +0.93% | +1.26% | +9.76% | +56.12% | 1.64TCr | ||
| -1.78% | -0.23% | -13.19% | -2.26% | 1.51TCr | ||
| +1.69% | -2.19% | -17.93% | -33.90% | 984.92Cr | ||
| -1.89% | +11.07% | -1.30% | +74.07% | 423.09Cr | ||
| Average | -0.94% | -1.89% | -18.00% | +3.40% | 3.26TCr | |
| Weighted average by Cap. | -1.04% | -3.74% | -22.16% | -0.05% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















